Peptide Tracker GLP-1: Regimen vs Peptidly: Peptide Tracker for "peptide tracker"
Peptide Tracker GLP-1: Regimen
Peptide tracker, peptide calculator & peptide app. GLP-1 tracker & injection log
Peptidly: Peptide Tracker
Track peptide cycles, doses, vial inventory & reconstitution — one private app.
Rank
4
For keyword
Rank
3
English (United States)Peptide tracker, peptide calculator & peptide app. GLP-1 tracker & injection log
Track peptide cycles, doses, vial inventory & reconstitution — one private app.
Peptide Tracker GLP-1: Regimen wins the first impression with a headline that promises a result, "that tells you if it's working", over a weight-journey chart, while Peptidly: Peptide Tracker's opener sells organisation, "Today's schedule, one screen." Peptidly: Peptide Tracker is the more legible set: every frame carries an eyebrow label plus filled-in UI, including a reconstitution calculator resolving to "DRAW TO 10 IU". The decisive fix is screenshot 1 of Peptide Tracker GLP-1: Regimen, which spends the highest-value slot on copy plus a fabricated star badge instead of the product.
Scanned screenshots4 a · 4 b
Only the first 4 screenshots from each side are sent to the AI. These are what users see in App Store and Google Play search results, so they carry most of the conversion weight.
App A
App B
Value Proposition
A leadsScreenshot 1's headline "that tells you if it's working" plus a 22 lbs weight-journey line promises an outcome, not just logging.
Peptidly: Peptide Tracker's first screenshot offers "Today's schedule, one screen.", organisation rather than results; the free, no-paywall stance stays in the description.
Clarity
B leadsScreenshots 2 to 4 show dose schedules, "1 vial left" badges and level curves, but slot one carries copy only, no interface.
Each frame pairs an eyebrow label like "RECONSTITUTION" with filled inputs: vial size 10 mg, BAC water 2 ml, "DRAW TO 10 IU".
Emotional Hook
Tied"Never miss a dose. Never run out." names relief, yet screenshot 3 is a compound list with no person or moment shown.
"Stop doing the maths." and "finally organised" carry relief, but all four frames are dark UI panels without human context.
Trust Signals
TiedScreenshot 1's "★★★★★ 4.8" laurel badge imitates Play's rating UI, which Play rejects; the 15,000-user claim sits only in the description.
No badge, testimonial or install count appears in any Peptidly: Peptide Tracker frame; "no ads and no paywalls" lives only in description text.
Reviews of "Peptide Tracker GLP-1: Regimen" cluster around multi-compound tracking, estimated serum-level charts and a responsive dev team, with the recurring friction being the one-peptide free tier and intermittent reminder/schedule reliability. Reviews of "Peptidly: Peptide Tracker" cluster around ease of setup, inventory plus dosing in one place and the app being free without ads, with the one repeated request being custom cycle lengths such as 6 days on, 1 day off. Both listings sit on strongly positive sentiment, and the differences are about pricing model and depth versus simplicity rather than stability.
App A
Pain points
Free tier limited to one peptide
MediumMissed doses and inconsistent reminders
MediumStrengths
Tracking multiple compounds on separate schedules
HighSerum level charts from half-life data
MediumResponsive developer and fast fixes
MediumApp B
Pain points
No custom cycle schedules
MediumStrengths
Easy setup compared with other trackers
HighInventory plus dose calculator in one app
HighFull feature set at no cost, no ads
MediumPeptide Tracker GLP-1: Regimen positions as a breadth-plus-outcomes hub, tracking "200+ compounds" across peptides, GLP-1s and TRT and promising to "see what's actually working" against health metrics. Peptidly: Peptide Tracker positions as the opposite: a narrow, free, private record-keeper that explicitly refuses the adjacent roles, "not a coach, not a prescriber". The mismatch is scope and stance, one selling an analytical system across every compound class, the other selling restraint, privacy and zero cost inside peptides alone.
App A
Positioning
Multi-compound tracking and insight hub
Target audience
Peptide, GLP-1, TRT and cycle users tracking together
Value promise
Log every compound and connect doses to real health outcomes
Tone
feature-dense, credentialed, benefit-forward
App B
Positioning
Private, free peptide record-keeping
Target audience
Self-directed users already running their own peptide protocols
Value promise
A private, ad-free place to log peptide cycles and vials
Tone
restrained, plain-spoken, practitioner-neutral
Gap
Peptide Tracker GLP-1: Regimen leads with breadth and analysis, 200+ compounds plus dose titration and metric correlation, while Peptidly: Peptide Tracker leads with restraint and cost, a peptide-only logbook that is "Free, with no ads and no paywalls".
Opportunity
Peptide Tracker GLP-1: Regimen can own the one-app-for-every-protocol claim for users stacking peptides with GLP-1s or TRT, a combined use case Peptidly: Peptide Tracker's peptide-only framing does not address.
Risk
The short description of Peptide Tracker GLP-1: Regimen spends most of its 80 characters repeating "peptide" variants rather than stating a benefit, so the first impression reads as coverage rather than outcome. Against a listing that says free and no paywalls in its opening line, a monetisation-forward description risks losing price-sensitive searchers before they reach the titration and metrics features.
Strategic advantage
Dose titration planning and dose-to-metric correlation speak to GLP-1 and TRT users on escalating protocols who need to justify a dose change, a decision-support motive that a pure logbook does not serve. The "15,000+ users" proof point supports that claim where the alternative offers no scale signal.
Missed opportunity
Neither listing speaks to the handover moment, showing a clinician or coach a clean protocol history at an appointment. Shareable protocol reports is an unclaimed angle for users who track precisely because someone else will ask.
App A
48
Peptide Tracker GLP-1: Regimen
Even
B wins
App B
52
Peptidly: Peptide Tracker
Even
Peptidly: Peptide Tracker holds rank 3 for peptide tracker with Peptide Tracker GLP-1: Regimen just behind at 4, and the gap is narrow enough that one conversion fix could swap the order. Peptidly: Peptide Tracker edges ahead on clarity of stance, not on keyword coverage, where Peptide Tracker GLP-1: Regimen is the stronger listing.
Why it wins
Peptidly: Peptide Tracker answers the peptide tracker query with one unambiguous promise, a peptide-only logbook that is "Free, with no ads and no paywalls", and every screenshot frame carries an eyebrow label over filled-in UI. Reviews reinforce it, clustering on free multi-peptide tracking, while Peptide Tracker GLP-1: Regimen carries the friction of a one-peptide free tier discovered after setup.
Biggest opportunity
The short description of Peptide Tracker GLP-1: Regimen already includes peptide tracker exactly, so the remaining gain is conversion: it is the only listing here offering dose titration and dose-to-metric correlation, a decision-support motive a pure logbook does not serve.
Next priority
Test screenshot 1 of Peptide Tracker GLP-1: Regimen with the titration or metric-correlation screen in the slot currently held by the copy panel and badge overlay, since that frame decides whether a peptide tracker searcher ever sees the analytical depth. Pair it with the one-peptide free limit stated plainly in the listing, which reviewers report finding only after setup.
Run your own comparison
Compare more apps, in any market or language.
See AI recommendations on how to beat your competitor.
Track keyword rankings across every store and locale. Free to start.
Try AppTracker free